| 2d ago | | ABBVIE INC: AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn.. |
| 4d ago | | ABBVIE INC: AbbVie to Present Data on Investigational Anti-Cancer Compounds at .. |
| 5d ago | DJ | AbbVie, Alvine Pharma to Collaborate on Investigational Drug for Celiac Disea.. |
| 5d ago | | ABBVIE INC: AbbVie and Alvine to Collaborate on Investigational Oral Therapy fo.. |
| 5d ago | | ABBVIE INC: AbbVie and Alvine to Collaborate on Investigational Oral Therapy fo.. |
| 05/10 | DJ | AbbVie Chief Scientific Officer John Leonard to Retire |
| 05/10 | DJ | Pfizer Has Second Recall of Thyroid-Disorder Drug Levoxyl |
| 05/07 | | ABBVIE INC: AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care.. |
| 05/06 | DJ | AbbVie's Investigational Hepatitis C Virus Regimen Gets Breakthrough-Therapy .. |
| 05/06 | | ABBVIE INC: AbbVie's Investigational HCV Regimen Receives Breakthrough Therapy .. |
| 04/30 | DJ | Vertex Pharmaceuticals Swings to 1st-Quarter Loss on Write-Down |
| 04/30 | DJ | Apple Launches Debt Sale at Record $17 Billion -Sources |
| 04/30 | DJ | Apple Launches Six-Part Debt Issue |
| 04/26 | DJ | AbbVie 1st-Quarter Profit Rises 9.6% on Strong Sales of Humira |
| 04/26 | DJ | AbbVie Profit Rises, Boosted by Humira Sales |
| 04/26 | DJ | AbbVie 1st-Quarter Profit Rises 9.6% on Strong Sales of Humira |
| 04/23 | | ABBVIE INC: New Data from AbbVie's Phase IIb Aviator Trial Demonstrate High Sus.. |
| 04/23 | DJ | Bristol Says Results of Hepatitis C Drug Trial are Positive |
| 04/17 | DJ | 'New Abbott' Labs Sees Sales Boost From Emerging Markets |
| 04/17 | DJ | Abbott 1st-Quarter Profit Fell 56% On Spinoff; Remaining Operations See Growt.. |
| 04/11 | | ABBVIE INC: ex-dividend day |
| 04/10 | | ABBVIE INC: StockCall Scrutinizes Pfizer, Merck & Co., Johnson & Johnson, and A.. |
| 04/08 | | ABBVIE INC: AbbVie to Host First-Quarter Earnings Conference Call |
| 04/03 | DJ | Pfizer Recalls Thyroid-Disorder Drug Over Odor Problem |
| 03/25 | DJ | Supreme Court Concerned About Drug Patent Settlements |
| 03/25 | DJ | Supreme Court Voices Concerns on Drug Patent Settlements |
| 03/21 | DJ | Enanta Pharmaceuticals Rises in IPO |
| 03/21 | DJ | Enanta Pharmaceuticals Rises in IPO |
| 03/21 | DJ | Enanta Pharmaceuticals Rises in IPO |
| 03/18 | DJ | AbbVie CEO 2012 Pay Up 40%, but Lags General Counsel's Total |
| 03/18 | DJ | AbbVie CEO 2012 Compensation Valued at $7.9 Million, Up More Than 40% |
| 03/13 | | ABBVIE INC: Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phas.. |
| 03/12 | | ABBVIE INC: StockCall Study on Merck & Co., Pfizer, Johnson & Johnson, and AbbV.. |
| 03/10 | DJ | ABBVIE INC: AbbVie Seeks To Block Release of Clinical Data |
| 03/10 | DJ | ABBVIE INC: AbbVie Seeks to Block Release of Clinical Trial Data -Report |
| 03/10 | | AbbVie seeks to stop EU agency releasing drug data |
| 03/08 | DJ | Pfizer Stops Developing Hepatitis C Drug, Cites Strategic Review |
| 03/05 | DJ | Rise of Generics, Specialty Drugs Prompt Shift in Drug Spending |
| 03/02 | DJ | Celgene's Psoriasis Drug Eases Symptoms in One Third of Patients |
| 02/28 | DJ | Busy Session for Corporate Bond Sales |
| 02/28 | DJ | Freeport-McMoRan Launches $6.5 Billion Bond Deal -Source |
| 02/27 | | ABBVIE INC: AbbVie to Present at Barclays Global Health Care Conference |
| 02/21 | DJ | Gimme Credit's Top Bonds List Led by Abbvie, Entergy, Phillips 66 |
| 02/20 | | ABBVIE INC: AbbVie to Present at Cowen and Company 33rd Annual Health Care Conf.. |
| 02/15 | DJ | AbbVie Authorizes $1.5 Billion Stock-Buyback Plan |
| 02/15 | | ABBVIE INC: AbbVie Declares Dividend and Announces Share Repurchase Program |
| 02/07 | DJ | Amgen Details Plan to Fight Patent Cliff, Lifts 2013 View |
| 02/07 | DJ | Amgen Details Plan to Fight Patent Cliff, Lifts 2013 View |
| 02/04 | DJ | Gilead Sciences Moves Closer to First Hepatitis C Pill |
| 01/30 | DJ | AbbVie Sees Humira Growth Offsetting Heart-Drug Weakness |
| 01/30 | DJ | AbbVie Issues Optimistic 2013 View on Strong Humira Sales |
| 01/23 | | Abbott results bode well for spun-off AbbVie |
| 01/23 | DJ | Abbott Labs 4th-Quarter Profit Fell 35% on Debt-Extinguishment Charges |
| 01/23 | DJ | Abbott Labs 4th-Quarter Profit Fell 35% on Debt-Extinguishment Charges |
| 01/23 | DJ | Correction to Abbott Labs Earnings Story |
| 01/23 | DJ | Abbott Labs Profit Falls 35% on Charges |
| 01/23 | DJ | Abbott Labs 4th-Quarter Profit Fell 35% on Debt-Extinguishment Charges |
| 01/21 | | ABBVIE INC: AbbVie Named to S&P 500 Dividend Aristocrat Index |
| 01/14 | DJ | Ford Steps on the Dividend Gas Pedal |
| 01/14 | | ABBVIE INC: Abbott and AbbVie Announce Investor Calls |
| 01/11 | DJ | Former Abbott Drug Unit Recalls Synthroid Again |
| 01/11 | DJ | Former Abbott Drug Unit Issues 2nd Recall of Synthroid in 6 Months |
| 01/04 | | ABBVIE INC: AbbVie Declares Inaugural Dividend |
| 01/02 | DJ | Abbott Labs, New Spinoff AbbVie Look Ahead to Distinct Challenges |
| 2012 | DJ | S&P: AbbVie to Replace Dell on S&P 100 |
